Phio Pharmaceuticals - 13 Year Stock Price History | PHIO

Historical daily share price chart and data for Phio Pharmaceuticals since 2012 adjusted for splits and dividends. The latest closing stock price for Phio Pharmaceuticals as of May 20, 2025 is 1.83.
  • The all-time high Phio Pharmaceuticals stock closing price was 1000000.00 on May 10, 2012.
  • The Phio Pharmaceuticals 52-week high stock price is 9.79, which is 435% above the current share price.
  • The Phio Pharmaceuticals 52-week low stock price is 0.97, which is 47% below the current share price.
  • The average Phio Pharmaceuticals stock price for the last 52 weeks is 3.00.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Phio Pharmaceuticals Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 1.8538 1.9000 6.6000 1.0100 1.8300 1.67%
2024 4.9034 6.9273 9.7200 1.7400 1.8000 -73.68%
2023 29.6187 40.5108 67.3920 6.6600 6.8400 -82.97%
2022 78.9083 117.7200 253.8000 36.1368 40.1760 -62.80%
2021 235.5390 303.4800 437.4000 107.1140 108.0000 -62.83%
2020 338.9630 1128.0000 1395.9000 181.4400 290.5200 -71.40%
2019 2022.4620 2077.8100 2940.3000 680.1290 1015.7400 -48.17%
2018 12309.7835 32670.0000 32670.0000 1693.4900 1959.6000 -94.06%
2017 37184.2163 42773.9000 51380.9000 25844.9000 33014.5000 -22.23%
2016 131388.4611 226136.0000 226136.0000 42221.5000 42453.1000 -81.29%
2015 385457.3571 950399.0000 956339.0000 213840.0000 226908.0000 -76.12%
2014 998299.2500 1000000.0000 1000000.0000 926639.0000 950399.0000 -4.96%
2013 1000000.0000 1000000.0000 1000000.0000 1000000.0000 1000000.0000 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.009B $0.000B
Phio Pharmaceuticals Corp is focused on developing immuno-oncology therapeutics based on its proprietary self-delivering RNAi therapeutic platform. The Company's pipeline consists of RXI-762 and RXI-804 which are in clinical stage. Phio Pharmaceuticals Corp, formerly known as RXi Pharmaceuticals Corporation, is based in Marlborough, United States.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $87.021B 32.64
Zoetis (ZTS) United States $72.987B 27.23
Daiichi Sankyo, - (DSNKY) Japan $49.540B 25.20
Takeda Pharmaceutical (TAK) Japan $45.278B 9.01
Sandoz Group AG (SDZNY) Switzerland $20.747B 0.00
Summit Therapeutics (SMMT) United States $17.831B 0.00
Merck (MKKGY) Germany $16.820B 12.32
United Therapeutics (UTHR) United States $13.772B 12.18
Shionogi (SGIOY) Japan $13.084B 13.11
Neurocrine Biosciences (NBIX) United States $12.155B 41.63
IPSEN (IPSEY) France $9.731B 0.00
Orion OYJ (ORINY) Finland $8.979B 24.28
Corcept Therapeutics (CORT) United States $7.934B 64.50
Stevanato Group S.p.A (STVN) Italy $7.504B 45.89
Madrigal Pharmaceuticals (MDGL) United States $6.455B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.976B 0.00
Grifols, S.A (GRFS) Spain $5.500B 0.00
Ionis Pharmaceuticals (IONS) United States $5.416B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.040B 15.33
Soleno Therapeutics (SLNO) United States $3.809B 0.00
Catalyst Pharmaceuticals (CPRX) United States $3.004B 10.53
Crinetics Pharmaceuticals (CRNX) United States $2.898B 0.00
Hypermarcas (HYPMY) Brazil $2.755B 18.12
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.351B 12.71
BioCryst Pharmaceuticals (BCRX) United States $2.170B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.090B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.833B 0.00
Guardian Pharmacy Services (GRDN) United States $1.678B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.638B 0.00
Indivior (INDV) United States $1.610B 6.83
Evotec AG (EVO) Germany $1.410B 0.00
ARS Pharmaceuticals (SPRY) United States $1.401B 0.00
Dyne Therapeutics (DYN) United States $1.325B 0.00
Ocular Therapeutix (OCUL) United States $1.196B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.090B 21.81
Harrow (HROW) United States $1.038B 0.00
Ardelyx (ARDX) United States $0.971B 0.00
Collegium Pharmaceutical (COLL) United States $0.958B 5.17
Avadel Pharmaceuticals (AVDL) Ireland $0.905B 0.00
Enliven Therapeutics (ELVN) United States $0.827B 0.00
Cronos Group (CRON) Canada $0.798B 0.00
Xeris Biopharma Holdings (XERS) United States $0.762B 0.00
Akebia Therapeutics (AKBA) United States $0.735B 0.00
AleAnna (ANNA) United States $0.667B 0.00
KalVista Pharmaceuticals (KALV) United States $0.600B 0.00
Xencor (XNCR) United States $0.574B 0.00
Bioventus (BVS) United States $0.569B 14.44
USANA Health Sciences (USNA) United States $0.560B 12.17
Elite Pharmaceuticals (ELTP) United States $0.552B 0.00
Regulus Therapeutics (RGLS) United States $0.545B 0.00
Savara (SVRA) United States $0.541B 0.00
Relay Therapeutics (RLAY) United States $0.502B 0.00
Zevra Therapeutics (ZVRA) United States $0.487B 0.00
CytoDyn (CYDY) United States $0.481B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.478B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.470B 0.00
Altimmune (ALT) United States $0.446B 0.00
Siga Technologies (SIGA) United States $0.433B 9.05
Tourmaline Bio (TRML) United States $0.427B 0.00
Organogenesis (ORGO) United States $0.410B 0.00
Verve Therapeutics (VERV) United States $0.390B 0.00
Oruka Therapeutics (ORKA) United States $0.386B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.352B 9.52
Heron Therapeutics (HRTX) United States $0.293B 0.00
Nature's Sunshine Products (NATR) United States $0.273B 25.22
Aquestive Therapeutics (AQST) United States $0.243B 0.00
ProKidney (PROK) United States $0.237B 0.00
MediWound (MDWD) Israel $0.222B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.195B 0.00
Wellgistics Health (WGRX) United States $0.193B 0.00
OmniAb (OABI) United States $0.189B 0.00
Nanobiotix S.A (NBTX) France $0.186B 0.00
Avita Medical (RCEL) United States $0.178B 0.00
4D Molecular Therapeutics (FDMT) United States $0.176B 0.00
Esperion Therapeutics (ESPR) United States $0.171B 0.00
Liminatus Pharma (LIMN) $0.164B 0.00
Journey Medical (DERM) United States $0.156B 0.00
Profound Medical (PROF) Canada $0.150B 0.00
Korro Bio (KRRO) United States $0.148B 0.00
Aldeyra Therapeutics (ALDX) United States $0.145B 0.00
Aclaris Therapeutics (ACRS) United States $0.141B 0.00
Inhibikase Therapeutics (IKT) United States $0.139B 0.00
Protara Therapeutics (TARA) United States $0.132B 0.00
Nektar Therapeutics (NKTR) United States $0.129B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.127B 0.00
Larimar Therapeutics (LRMR) United States $0.125B 0.00
Lyell Immunopharma (LYEL) United States $0.122B 0.00
Innate Pharma SA (IPHYF) France $0.122B 0.00
Achieve Life Sciences (ACHV) Canada $0.115B 0.00
VAXART, INC (VXRT) United States $0.114B 0.00
Lexeo Therapeutics (LXEO) United States $0.109B 0.00
Fractyl Health (GUTS) United States $0.104B 0.00
Cassava Sciences (SAVA) United States $0.100B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.099B 0.00
OptiNose (OPTN) United States $0.098B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.095B 0.00
Cardiol Therapeutics (CRDL) Canada $0.093B 0.00
Galectin Therapeutics (GALT) United States $0.084B 0.00
Dominari Holdings (DOMH) United States $0.082B 0.00
Champions Oncology (CSBR) United States $0.082B 13.45
Cumberland Pharmaceuticals (CPIX) United States $0.082B 60.56
Arch Biopartners (ACHFF) Canada $0.080B 0.00
Inotiv (NOTV) United States $0.077B 0.00
Pyxis Oncology (PYXS) United States $0.076B 0.00
Telomir Pharmaceuticals (TELO) United States $0.076B 0.00
ESSA Pharma (EPIX) Canada $0.075B 0.00
Unicycive Therapeutics (UNCY) United States $0.073B 0.00
Surrozen (SRZN) United States $0.069B 0.00
Assertio Holdings (ASRT) United States $0.068B 0.00
Metagenomi (MGX) United States $0.064B 0.00
Nutriband (NTRB) United States $0.064B 0.00
Vivani Medical (VANI) United States $0.063B 0.00
Context Therapeutics (CNTX) United States $0.063B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.060B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Gain Therapeutics (GANX) United States $0.058B 0.00
Prelude Therapeutics (PRLD) United States $0.052B 0.00
Mural Oncology (MURA) Ireland $0.048B 0.00
Century Therapeutics (IPSC) United States $0.048B 0.00
PMV Pharmaceuticals (PMVP) United States $0.045B 0.00
Karyopharm Therapeutics (KPTI) United States $0.044B 0.00
Avalo Therapeutics (AVTX) United States $0.043B 0.00
NRx Pharmaceuticals (NRXP) United States $0.042B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.042B 0.00
Iterum Therapeutics (ITRM) Ireland $0.040B 0.00
ElectroCore (ECOR) United States $0.039B 0.00
Acrivon Therapeutics (ACRV) United States $0.037B 0.00
Rafael Holdings (RFL) United States $0.034B 0.00
SCYNEXIS (SCYX) United States $0.032B 0.00
FibroGen (FGEN) United States $0.032B 0.00
PolyPid (PYPD) Israel $0.029B 0.00
Tempest Therapeutics (TPST) United States $0.025B 0.00
CASI Pharmaceuticals (CASI) China $0.023B 0.00
Enlivex Therapeutics (ENLV) Israel $0.023B 0.00
Natural Alternatives (NAII) United States $0.020B 0.00
DURECT (DRRX) United States $0.020B 0.00
BioVie (BIVI) United States $0.020B 0.00
Lipocine (LPCN) United States $0.019B 0.00
Jupiter Neurosciences (JUNS) United States $0.019B 0.00
VYNE Therapeutics (VYNE) United States $0.019B 0.00
Mannatech (MTEX) United States $0.017B 0.00
TherapeuticsMD (TXMD) United States $0.017B 0.00
Relmada Therapeutics (RLMD) United States $0.017B 0.00
GlycoMimetics (GLYC) United States $0.017B 0.00
Ernexa Therapeutics (ERNA) United States $0.014B 0.00
MEI Pharma (MEIP) United States $0.014B 0.00
Vivos Therapeutics (VVOS) United States $0.014B 0.00
ProPhase Labs (PRPH) United States $0.013B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.013B 0.00
Scienture Holdings (SCNX) United States $0.012B 0.00
Cosmos Health (COSM) United States $0.012B 0.00
BioLineRx (BLRX) Israel $0.011B 0.00
Talphera (TLPH) United States $0.010B 0.00
Minerva Neurosciences (NERV) United States $0.010B 1.77
Kiora Pharmaceuticals (KPRX) United States $0.010B 0.00
Biomerica (BMRA) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Ainos (AIMD) United States $0.008B 0.00
Carisma Therapeutics (CARM) United States $0.008B 0.00
Mangoceuticals (MGRX) United States $0.008B 0.00
Citius Pharmaceuticals (CTXR) United States $0.008B 0.00
Klotho Neurosciences (KLTO) United States $0.008B 0.00
Traws Pharma (TRAW) United States $0.007B 0.00
Lyra Therapeutics (LYRA) United States $0.007B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
Indaptus Therapeutics (INDP) United States $0.006B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.006B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.006B 0.00
Plus Therapeutics (PSTV) United States $0.006B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
Alaunos Therapeutics (TCRT) United States $0.004B 0.00
Conduit Pharmaceuticals (CDT) United States $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
PainReform (PRFX) Israel $0.004B 0.00
Incannex Healthcare (IXHL) Australia $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Redhill Biopharma (RDHL) Israel $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.001B 0.00
SHINECO (SISI) China $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.001B 0.00
Petros Pharmaceuticals (PTPI) United States $0.000B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Aditxt (ADTX) United States $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00